Have we gotten better at diagnosing PDAC before it is too late?: Temporal Trends in Stage at Diagnosis of Pancreatic Ductal Adenocarcinoma in the United States
A retrospective analysis of US SEER data from 2004 to 2022 reveals a significant temporal shift toward earlier-stage diagnosis of pancreatic ductal adenocarcinoma, particularly for localized disease, likely driven by improved imaging and screening efforts, though further research is needed to confirm if this translates to improved survival.